Sponsor:
Louisiana State University Health Sciences Center in New Orleans
Code:
NCT05663684
Conditions
Epiphora
Dacryostenosis
Dacryocystitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
Balanced salt solution
Brief summary:
Conditions
Epiphora
Dacryostenosis
Dacryocystitis
Study ID
NCT05663684
Start date
Jun 30, 2020
Status verified date
Dec, 2022
Completion date
Jan 31, 2023
Anticipated
Primary completion date
Dec 30, 2022
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
145 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Participants with no obstruction of the lacrimal system
experimental: Participants with obstruction of the lacrimal system
Interventions
Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
Balanced salt solution
Primary outcome measure
Central contacts
Locations
Louisiana State University Health Sciences Center
Recruiting
New Orleans, Louisiana, United States, 70112
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Last update posted
Dec 23, 2022
Last verified
Dec, 2022
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Louisiana State University Health Sciences Center in New Orleans on 2022-12-23.